HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1
This study has been completed.
Sponsor:
University of Washington
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00084175
First received: June 8, 2004
Last updated: April 13, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.
| Condition | Intervention | Phase |
|---|---|---|
|
Behavior Therapy |
Behavioral: Behavior Therapy |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Primary Purpose: Treatment |
| Official Title: | HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs |
Resource links provided by NLM:
Further study details as provided by National Institute on Drug Abuse (NIDA):
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00084175
Locations
| United States, California | |
| Matrix Institute on Addictions | |
| Rancho Cucamonga, California, United States, 91730 | |
| San Francisco General Hospital | |
| San Francisco, California, United States, 94110 | |
| United States, Connecticut | |
| Hartford Dispensary | |
| New Britain, Connecticut, United States, 06051 | |
| CT Renaissance, Inc. | |
| Norwalk, Connecticut, United States, 06852 | |
| United States, New Mexico | |
| Life Link | |
| Santa Fe, New Mexico, United States, 87505 | |
| United States, New York | |
| Staten Island University Hospital | |
| Staten Island, New York, United States, 10309 | |
| United States, North Carolina | |
| Addiction Drug Services-Highpoint | |
| High Point, North Carolina, United States, 27265 | |
| South Light | |
| Raleigh, North Carolina, United States, 27604 | |
| United States, Ohio | |
| Comprehensive Addiction Services System | |
| Toledo, Ohio, United States, 43620 | |
| United States, Pennsylvania | |
| The Consortium | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Thomas Jefferson Intensive Sub. Abuse TP | |
| Philadelphia, Pennsylvania, United States, 19107 | |
| United States, South Carolina | |
| LRADAC-Lexington-Richmond Alcohol & Drug Council | |
| Columbia, South Carolina, United States, 29204 | |
| United States, Washington | |
| Evergreen Treatment Services | |
| Seattle, Washington, United States, 98134 1618 | |
| United States, West Virginia | |
| Prestera Center for Mental Health Svcs. | |
| Huntington, West Virginia, United States, 25704 | |
Sponsors and Collaborators
University of Washington
Investigators
| Principal Investigator: | Donald Calsyn, Ph.D. | University of Washington |
More Information
No publications provided by National Institute on Drug Abuse (NIDA)
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Donald Calsyn, Ph.D., University of Washington |
| ClinicalTrials.gov Identifier: | NCT00084175 History of Changes |
| Other Study ID Numbers: | NIDA-CTN-0018-1 |
| Study First Received: | June 8, 2004 |
| Last Updated: | April 13, 2010 |
| Health Authority: | United States: Federal Government |
ClinicalTrials.gov processed this record on June 18, 2013